Skip to main content
. 2013 Aug 20;16(8):405–410. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2013.08.03

2.

两组患者治疗疗效的比较

Comparison of the efficacy of treatments in the two groups

Group n CR (%) PR (%) SD (%) PD (%) ORR (%) DCR (%) mPFS (month)
CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease; ORR: objective response rate; mPFS: median progression-free survival.
Pemetrexed 23 0(0) 3(13.0) 4(17.3) 16 (69.6) 3 (13.0) 7 (30.4) 3.1
Gefitinib 23 1 (4.3) 3 (13.0) 5(21.7) 14 (60.9) 4(17.3) 9 (39.1) 4.4
Statistic u=0.4060 u=0.6199 t=1.4728
P > 0.05 > 0.05 > 0.05